ES480448A1 - Procedimiento de fabricacion de medicamentos inmunobioterapicos. - Google Patents

Procedimiento de fabricacion de medicamentos inmunobioterapicos.

Info

Publication number
ES480448A1
ES480448A1 ES480448A ES480448A ES480448A1 ES 480448 A1 ES480448 A1 ES 480448A1 ES 480448 A ES480448 A ES 480448A ES 480448 A ES480448 A ES 480448A ES 480448 A1 ES480448 A1 ES 480448A1
Authority
ES
Spain
Prior art keywords
treating infections
respiratory passages
bacterial lysates
image
respiratory
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES480448A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
OM LAB SA
OM Pharma SA
Original Assignee
OM LAB SA
Laboratories Om SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=4299594&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES480448(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by OM LAB SA, Laboratories Om SA filed Critical OM LAB SA
Publication of ES480448A1 publication Critical patent/ES480448A1/es
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biotechnology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • General Engineering & Computer Science (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

Procedimiento de fabricación de medicamentos inmunobioterápicos, contra las enfermedades de las vías respiratorias, caracterizado porque se cultivan en un medio de cultivo unas bacterias que provienen de por lo menos una de las cepas siguientes: Staphylococcus aureus I-049, I-050, I-051, I-052, I-053, I-054. Streptococcus viridians I-046, I- 047, I-048. Neisseria catarrhalis I-045 y por lo menos una de las cepas siguientes: Hemophilus influenzae sero tipo b NCTC 8467, Diplococcus pneumoniaes serotipos, 1, 2, 3. Y 47 NCTC 7465, 7466, 7978, 10319. Klebsiella pneumoniae NCTC 204, 5056, Klebsiella ozaenae NCTC 5050, Streptococcus pyogenes serogrupo A NCTC 8191, Neisseria catarrahalis NCTC 3622, 3625 porque se prepara un lisado de las bacterias así cultivadas y porque este lisado se incorpora en un soporte farmaceuticamente aceptable.
ES480448A 1978-05-26 1979-05-10 Procedimiento de fabricacion de medicamentos inmunobioterapicos. Expired ES480448A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH580578A CH633188A5 (fr) 1978-05-26 1978-05-26 Medicament contre des maladies infectieuses des voies respiratoires.

Publications (1)

Publication Number Publication Date
ES480448A1 true ES480448A1 (es) 1979-12-16

Family

ID=4299594

Family Applications (1)

Application Number Title Priority Date Filing Date
ES480448A Expired ES480448A1 (es) 1978-05-26 1979-05-10 Procedimiento de fabricacion de medicamentos inmunobioterapicos.

Country Status (15)

Country Link
JP (1) JPS54154509A (es)
BE (1) BE876164A (es)
CH (1) CH633188A5 (es)
CS (1) CS222673B2 (es)
DD (1) DD143729A5 (es)
DE (1) DE2917730C2 (es)
ES (1) ES480448A1 (es)
FR (1) FR2426470A1 (es)
GB (1) GB2021415B (es)
HU (1) HU180005B (es)
IT (1) IT1116213B (es)
PL (1) PL126416B1 (es)
PT (1) PT69674A (es)
RO (1) RO78451A (es)
YU (1) YU41864B (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2550707B1 (fr) * 1983-08-17 1986-02-28 Lipha Medicament immunomodulateur d'origine biologique et son procede de preparation
CH680045A5 (es) * 1990-02-16 1992-06-15 Om Lab Sa
CH685498A5 (fr) * 1992-02-14 1995-07-31 Om Lab Sa Extrait de macromolécules bactériennes, procédé pour sa préparation et composition pharmaceutique contenant cet extrait.
WO1997045530A1 (fr) * 1996-05-27 1997-12-04 UZILOVA, Irina Semenovna, Heiress of UZILOV Utilisation de souches de streptococcus faecium et composition a base de ces souches
SE511648C2 (sv) * 1998-04-17 1999-11-01 Bacterum Ab Streptokockpreparat för behandling av öroninflammation
PL2114421T3 (pl) * 2007-03-05 2018-07-31 Om Pharma Ekstrakt bakteryjny do stosowania względem zaburzeń oddechowych i sposób jego wytwarzania
CN104922330A (zh) * 2015-07-15 2015-09-23 龚灿锋 一种治疗扁桃体炎的中药

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE543985A (es) *
FR2892M (fr) * 1963-07-25 1964-11-02 Inst Rech Scient Substances a action immunisante et désensibilisante.
FR6513M (es) * 1967-07-12 1968-12-02
FR7010M (es) * 1967-11-10 1969-06-02
FR7461M (es) * 1968-06-19 1970-01-05
US3929994A (en) * 1969-05-20 1975-12-30 Roussel Uclaf Anti-inflammatory glycoprotein compositions and method of use
NL174267B (nl) * 1969-05-20 Roussel Uclaf Verbetering van de werkwijze voor de bereiding van een somatisch antigeen volgens het nederlandse octrooischrift 169754 en werkwijze ter bereiding van een farmaceutisch preparaat.
BE795417A (fr) * 1972-02-15 1973-08-14 Roussel Uclaf Nouveaux composes d'origine-bacterienne et procede d'obtention
FR2253499B1 (es) * 1973-12-10 1977-11-04 Fabre Sa Pierre
GB1518277A (en) * 1974-09-06 1978-07-19 Inst Rech Chem Et Biolog Appli Antigenic composition
FR2307542A1 (fr) * 1975-04-14 1976-11-12 Synthelabo Nouvelle preparation immunostimulante
FR2315944A1 (fr) * 1975-07-04 1977-01-28 Tournade Francois Preparation pharmaceutique presentant une action de stimulation immunitaire non specifique de l'organisme

Also Published As

Publication number Publication date
FR2426470A1 (fr) 1979-12-21
DE2917730C2 (de) 1986-04-03
CS222673B2 (en) 1983-07-29
JPS6337770B2 (es) 1988-07-27
DD143729A5 (de) 1980-09-10
IT1116213B (it) 1986-02-10
FR2426470B1 (es) 1983-08-05
PL215824A1 (es) 1980-02-11
YU123679A (en) 1983-04-30
DE2917730A1 (de) 1979-11-29
GB2021415A (en) 1979-12-05
PT69674A (pt) 1979-06-01
BE876164A (fr) 1979-09-03
IT7949157A0 (it) 1979-05-24
PL126416B1 (en) 1983-08-31
HU180005B (en) 1983-01-28
CH633188A5 (fr) 1982-11-30
GB2021415B (en) 1983-03-30
YU41864B (en) 1988-02-29
RO78451A (ro) 1982-02-26
JPS54154509A (en) 1979-12-05

Similar Documents

Publication Publication Date Title
ES477591A1 (es) Procedimiento para la obtencion de preparados farmaceuticos que contienen un derivado de cefem.
ES8304143A1 (es) "procedimiento para la preparacion de derivados de cefem".
AU5554986A (en) Treatment of viral diseases with azolylmethyloxiranes
PL307914A1 (en) Lipopetide derivatives, method of obtaining them and therapeutic agents containing such compounds
WO1988005046A3 (en) Insecticidal pyrazolines
ES474592A1 (es) Procedimiento para la preparacion de derivados de imidazoli-nina
FI964162A (fi) Aineyhdistelmä ja menetelmä kasvisairauksien säätämiseksi
YU194691A (sh) Benzodiazepinoni
ES8200921A1 (es) Procedimiento para la obtencion de nikkomicinas de efecto pesticida
ES8603497A1 (es) Procedimiento para preparar derivados de cefalosporina
ES480448A1 (es) Procedimiento de fabricacion de medicamentos inmunobioterapicos.
ES458070A1 (es) Un procedimiento para la produccion del compuesto antibioti-co msd 890 a.
AU3277384A (en) Scalp treatment by lipase application
ES476109A1 (es) Procedimiento para la preparacion de derivados de cefalospo-rina
MY129859A (en) Bacterial strains of the bacterium bacillus thuringiensis and uses therefor
Brook Role of anaerobic bacteria in chronic otitis media and cholesteatoma
ES476154A1 (es) Un procedimiento para la preparacion de nuevos derivados de cefalosporina
EP0196628A3 (en) Ansamycin antibioticum, microbiological process for its preparation and its use as a medicament
ES8200680A1 (es) Un procedimiento para la preparacion de fenil-quinolicidinas
EA199800558A1 (ru) Композиция для криоконсервации органов и лечения вирусных и бактериальных инфекций
ES8705452A1 (es) Procedimiento para la obtencion de compuestos de b-lactama
ES8707734A1 (es) Procedimiento para la obtencion de cefalosporinas
ES508985A0 (es) Procedimiento microbiologico para la obtencion de un nuevo compuesto antibiotico de la cepa streptomyces.
ES8402286A1 (es) Procedimiento para la obtencion de antibiotico de p-lactama.
SE7706730L (sv) Nya antibiotika, neoviridogriseiner och sett att framstella desamma